CRH Medical Corporation (TSX:CRH) acquired 85% stake in New England Anesthesia Associates LLC on May 1, 2021. The transaction is accretive. New England Anesthesia Associates LLC current estimated annualized revenue run-rate is approximately $3.6 million with operating EBITDA margins equal to approximately 40% which is generally consistent with other similar acquisitions made by CRH Medical Corporation. CRH Medical Corporation (TSX:CRH) completed the acquisition of 85% stake in New England Anesthesia Associates LLC on May 1, 2021.